Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Petr O. Ilyinskii, Takashi Kishimoto(Boehringer Ingelheim (United States)), Lynnelle A. Pittet(Selecta Biosciences (United States)), Jinjun Shi(Brigham and Women's Hospital), Ulrich H. von Andrian(Harvard University), Róbert Langer(Massachusetts Institute of Technology), Omid C. Farokhzad(Brigham and Women's Hospital), Conlin P. O’Neil(Selecta Biosciences (United States)), Aleksandar F. Radovic‐Moreno(Harvard–MIT Division of Health Sciences and Technology), Pamela A. Basto(Harvard–MIT Division of Health Sciences and Technology), Elena Tonti(McMaster University), Matteo Iannacone(Harvard University), David H. Altreuter(Selecta Biosciences (United States)), Frank Alexis(Universidad Yachay Tech), Lloyd Johnston(Selecta Biosciences (United States)), Erica Browning
Cited by 165
Related Papers
Cancer nanomedicine: progress, challenges and opportunities
|Nature reviews. Cancer|2016|5.6k
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k